Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics
Go back to Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics| Sinovac Biotech, Ltd (NASDAQ: SVA) | Delayed: 6.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.47 | 52 Week High | $7.16 | |||
| Open | $0.08 | 52 Week Low | $4.38 | |||
| Day High | $6.47 | P/E | N/A | |||
| Day Low | $6.47 | EPS | $-0.08 | |||
| Volume | 39,200 | |||||
